Sanlao, Lumabao B.

HRN: 00-99-67  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2026
CEFTRIAXONE 1G (VIAL)
03/01/2026
03/08/2026
IV
2g
Q24
Cholecystitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: